Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.
The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.
The "Global Telmisartan Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Telmisartan market with detailed market segmentation by indication, composition, distribution channel and geography. The global Telmisartan market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players and offers key trends and opportunities in the market.
The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
Get more information on this report :
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Telmisartan market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Telmisartan market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Telmisartan market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Telmisartan market in these regions.
Get more information on this report :
The reports cover key developments in the Telmisartan market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Telmisartan market are anticipated to lucrative growth opportunities in the future with the rising demand for Telmisartan in the global market. Below mentioned is the list of few companies engaged in the Telmisartan market.
The report also includes the profiles of key Telmisartan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Hikma Pharmaceuticals PLC
Exelan Pharmaceuticals, Inc.
Macleods Pharmaceuticals Ltd.
Zydus Pharmaceuticals, Inc.
Torrent Pharmaceuticals Ltd.
Sandoz International GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.